Cover Image

Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD

BackgroundIt is unclear whether patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are allowed variable low levels of alcohol. This study aimed to evaluate the effect of mild-moderate alcohol consumption on the biochemical and histological characteristics of patients with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ang Huang (Author), Cailun Zou (Author), Zhe Dai (Author), Ying Sun (Author), Jing Wang (Author), Shuhong Liu (Author), Lin Han (Author), Songhai Chen (Author), Qingsheng Liang (Author), Chunyan Wang (Author), Yingjie Zhuang (Author), Tong Dang (Author), Binxia Chang (Author), Yijin Wang (Author), Zhengsheng Zou (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013
by: Binxia Chang, et al.
Published: (2017)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
by: Qiaoling Wang, et al.
Published: (2021)

Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury
by: Ruiyuan Yang, et al.
Published: (2022)

The spectrum of biopsy-proven renal diseases in Korea
by: Beom Jin Lim
Published: (2020)

Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
by: Yiyun Wang, et al.
Published: (2020)

Clinical and Histological Predictors of Renal Survival in Patients with Biopsy-Proven Diabetic Nephropathy
by: Ting Zhou, et al.
Published: (2021)

Clinical, electrophysiological, and histopathological profile of biopsy-proven vasculitic neuropathy
by: Suchitra Deolalikar, et al.
Published: (2020)

IL-33-ST2 Axis in Liver Disease: Progression and Challenge
by: Zijian Sun, et al.
Published: (2017)

Advanced liver fibrosis, but not MASLD, is associated with accelerated biological aging: a population-based study
by: Chengcheng Tong, et al.
Published: (2024)

Early clinical course of biopsy-proven IgA vasculitis nephritis
by: Sarina Butzer, et al.
Published: (2022)

Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney disease
by: Ji In Park, et al.
Published: (2012)

Histopathological yield in different types of bronchoscopic biopsies in proven cases of pulmonary tuberculosis
by: Nalini Gupta, et al.
Published: (2015)

Emerging therapies for MASLD and their impact on plasma lipids
by: Madison Nguyen, et al.
Published: (2024)

Lycorine ameliorates liver steatosis, oxidative stress, ferroptosis and intestinal homeostasis imbalance in MASLD mice
by: Ziwen Wang, et al.
Published: (2024)

Magnetic resonance evaluation with staging of biopsy proven cases of cancer cervix and to compare with FIGO staging
by: Parul Dutta, et al.
Published: (2016)

A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropathy
by: Woo Chul Joo, et al.
Published: (2012)

Pattern of kidney diseases in Northern India: an overview through histopathological findings in biopsy-proven cases
by: Sanjay Kumar, et al.
Published: (2020)

COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease
by: Juan León Román, et al.
Published: (2021)

ENDOSCOPIC BIOPSY PROVEN CO-INFECTION OF HELICOBACTER PYLORI AND GIARDIA LAMBLIA IN ADULT POPULATION OF KARACHI CITY
by: Syed Mehmood Hasan, et al.
Published: (2024)

Five-Year study on renal outcomes in biopsy-proven focal segmental glomerulosclerosis patients in Shiraz, Iran
by: Maryam Pakfetrat, et al.
Published: (2024)

328 Immunosuppressive therapies in children with biopsy-proven iga vasculitis nephritis: a tertiary centre experience
by: Eugene Yu-hin Chan, et al.
Published: (2021)

Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience
by: Nicole Nesselhauf, et al.
Published: (2016)

Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10
by: Yanying Yang, et al.
Published: (2024)

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives
by: Zherui Liu, et al.
Published: (2023)

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
by: Xiang Xiao, et al.
Published: (2022)

Comparison of Gonadotropin with Gonadotropin and Letrozole Combination in Infertile Women with Biopsy - Proven Endometriosis Undergoing Intracytoplasmic Sperm Injection
by: Burak Tanır, et al.
Published: (2016)

Primary Angiitis of the Central Nervous System in Adults: A Comprehensive Review of 76 Biopsy-Proven Case Reports
by: Lu P, et al.
Published: (2023)

Pathological discrepancy between colposcopic directed cervical biopsy and Loop Electrosurgical-Excision Procedures (LEEPs) in patients with biopsies proven high grade cervical intraepithelial neoplasia
by: Sitchuphong Noothong, et al.
Published: (2017)

Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches
by: Tatjana Radosavljevic, et al.
Published: (2024)

Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges
by: Ying Yang, et al.
Published: (2024)

A unique presentation of a rare disease: biopsy proven systemic lupus erythematosus and microscopic polyangitis: an overlap syndrome
by: Diana Meyler, et al.
Published: (2019)

Clinical and laboratory features of 496 cases of biopsy-proven lupus nephritis; a study at Shiraz University of Medical Sciences, Iran
by: Seyed Mohammad Owji, et al.
Published: (2022)

Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH
by: Deqiang Zhang, et al.
Published: (2024)

Screening for social determinants of health among populations at risk for MASLD: a scoping review
by: Rebecca G. Kim, et al.
Published: (2024)

Guilty until proven innocent?
by: Heath B McAnally
Published: (2022)

Beyond Provenance New Approaches to Interpreting the Chemistry of Archaeological Copper Alloys
by: Pollard, Mark
Published: (2018)

Beyond Provenance New Approaches to Interpreting the Chemistry of Archaeological Copper Alloys
Published: (2018)

Biopsy-proven diagnoses associated with monodactylous longitudinal nail plate change in a diverse patient population: A retrospective cross-sectional study
by: Jeffrey N. Li, MD, et al.
Published: (2024)

Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives
by: Torre E, et al.
Published: (2024)

Beyond Provenance (Volume 6.0)
by: Pollard, Mark
Published: (2018)